DNOV is the ticker for the FT Vest U.S. Equity Deep Buffer ETF - November, part of the expanding group of defined outcome or buffered ETFs. Rather than offering full market exposure like a standard index fund, this vehicle targets a specific range of results: upside participation in the S&P 500 up to a set cap, paired with protection against a defined portion of losses. This overview examines the fund’s structure, holdings, and overall approach.
The investment objective centers on delivering returns, before fees and expenses, that align with the price performance of the SPDR S&P 500 ETF Trust (SPY) up to a predetermined cap while buffering losses between -5% and -30% over the outcome period. For the period starting November 2025, the stated upside cap stood at 12.93% before fees and expenses.
DNOV operates as an actively managed ETF. Instead of holding S&P 500 shares directly, it invests primarily in FLexible EXchange Options, or FLEX Options, tied to SPY. These customized contracts let the fund set precise strike prices and expirations, allowing it to build the capped and buffered profile through a combination of calls and puts.
First Trust serves as issuer and advisor, with Vest Financial LLC acting as sub-advisor. The fund launched on November 15, 2019, trades on Cboe BZX, and carries a 0.85% expense ratio. It is non-diversified, with holdings concentrated in a limited set of FLEX Options on SPY plus a small cash allocation. Sector exposure generally tracks large-cap U.S. equities, led by technology, financials, and healthcare, though actual returns depend on the cap and buffer rather than full market movement. I also checked this using Tickeron’s AI Screener to see how the fund compares with peers in the buffered ETF space.
The defined-risk structure draws interest from those seeking large-cap equity exposure without full downside participation. The buffer is meant to absorb losses in the underlying ETF between -5% and -30% across the outcome period, providing a layer of protection unavailable in plain index funds. In return, upside remains limited by the cap. This positioning may suit investors looking for a more measured equity allocation or a way to reduce volatility relative to the broader market while still gaining diversification through large-cap exposure.
The buffer leaves the first 5% of losses unprotected and does not cover declines beyond 30%. It applies only over the full outcome period, not day to day, and is calculated before fees. The cap prevents full participation in strong rallies, and that cap resets each November based on then-current market conditions, leading to year-to-year variation. Investors entering mid-period may face different effective parameters than those holding from the start. The 0.85% expense ratio exceeds many standard index ETFs, and the options-based strategy adds complexity along with option-pricing and market risks. Underperformance versus a simple buy-and-hold strategy remains possible.
When evaluating structured products like this, I often rely on Tickeron’s AI Screener to quickly compare technical indicators, volatility profiles, and sector trends across similar ETFs. The platform lets me apply custom filters and review AI-generated signals in one place, which helps surface ideas that fit a defined-outcome strategy without spending hours on manual screens.
DNOV provides broad U.S. large-cap equity exposure through a buffered, capped, options-based design that distinguishes it from conventional index funds. Its defined-outcome framework offers investors a structured way to seek reduced downside over each annual period while accepting limited upside. Within the buffered-ETF category, it stands as a clear example of how these strategies have moved into accessible ETF formats for those managing equity risk.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
DNOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 35 cases where DNOV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 80%.
Following a +0.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where DNOV advanced for three days, in 250 of 403 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 339 of 511 cases where DNOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The 10-day RSI Indicator for DNOV moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 55 similar instances where the indicator moved out of overbought territory. In 16 of the 55 cases, the stock moved lower in the following days. This puts the odds of a move lower at 29%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DNOV as a result. In 35 of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 51%.
The Moving Average Convergence Divergence Histogram (MACD) for DNOV turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 23 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 46%.
DNOV moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DNOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.